NLM Logo

3'-deamino-3'-hydroxydoxorubicin MeSH Supplementary Concept Data 2024


MeSH Supplementary
3'-deamino-3'-hydroxydoxorubicin
Unique ID
C042907
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C042907
Entry Term(s)
3'-deamino-4'-epi-3'-hydroxydoxorubin
3-DHD
hydroxyrubicin
Pharm Action
Topoisomerase II Inhibitors
Registry Number
73113-90-3
CAS Type 1 Name
5,12-Naphthacenedione, 10-((2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
Previous Indexing
DOXORUBICIN/*analogs (84-88)
Heading Mapped to
Epirubicin / *analogs & derivatives
Frequency
11
Note
substitution of the basic amino group at the C-3' of doxorubicin by a hydroxyl group overcomes recognition of the multidrug resistant P-glycoprotein and limits cardiotoxicity; structure given in first source
Source
J Antibiot (Tokyo) 1984;37(8):853
Date of Entry
1984/11/01
Revision Date
2013/08/12
3'-deamino-3'-hydroxydoxorubicin Preferred
3'-deamino-4'-epi-3'-hydroxydoxorubin Narrower
page delivered in 0.004s